Warad SB, Pattanashetti J, Kalburgi N, Koregol A, Rao S

Language: English
References: 26
Page: 137-146
PDF size: 170.73 Kb.

ABSTRACT

Despite the reported effects of smokeless tobacco (ST) on the periodontium and high prevalence of ST use in rural populations and in males studies on this specific topic are limited. The purpose of this cross-sectional investigation was to measure lipid peroxidation (as an end product of oxidative stress) end product i.e. Malondialdehyde (MDA) in saliva of patients with gingivitis, chronic periodontitis and to assess the influence of smokeless tobacco on Salivary Malondialdehyde (S-MDA). Total 30 patients with gingivitis, 30 with chronic periodontitis and 30 Smokeless Tobacco Chewers with Chronic Periodontitis and 30 periodontally healthy subjects were included in the study. Plaque Index (PI), Gingival Index (GI), Probing Pocket Depth (PD), and Clinical Attachment Loss (CAL) were recorded followed by stimulated Saliva sample collection. Salivary MDA Levels were assessed by UV Spectrophotometry. There was a statistically significant increase in the salivary MDA levels in gingivitis, chronic periodontitis and in smokeless tobacco chewers with chronic periodontitis when compared with healthy group. Higher salivary MDA levels in gingivitis group, chronic periodontitis, and smokeless tobacco chewers with chronic periodontitis reflects increasedoxygen radical activity during periodontal inflammation.

REFERENCES

1. Loe H., Teilade E., Jensen S.B. Experimental gingivitis in man. J Periodontol 1965; 36 (3): 177-87.

2. Miller D.R., Lamster I.B., Chasens A.l. Role of the polymorphonuclear leukocyte in periodontal health and diseae. J Clin Periodontal. 1984; 11: 1-15.

3. Page R.C., Kornman K.S. The pathogenesis of human periodontitis: an introduction. Periodontal 2000; 1997; 14: 9-11.

4. Halliwell B. Oral inflammation and reactive species: a missed opportunity. Oral Dis 2000; 6: 136-137.

5. Canakci C.F., Cieek Y., Canakci V. Reactive oxygen species and human inflammatory periodontal diseases. Biochemistry (Mose) 2005; 70: 619-628.

6. Waddington R.J., Moseley R., Embery G. Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis 2000; 6: 138-151.

7. Valko M., Leibfritz D., Moneol J., Cronin M.T., Mazur M., Telser J. Free radicals And antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.

8. Djordjevic V.B. Free radicals in cell biology. Int Rev Cytol. 2004; 237: 57-89

9. Sies H. Oxidative stress: Oxidants and Antioxidants. Academic Press, New York 1991.

10. Tsai C. C., H. S. Chen, S. L. Chen, et al. Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodont Res 2005; 40; 378-384.

11. Onorato J.M., Thorpe S.R., Baynes; J.W. Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease.Ann NY AcadSci 1998; 854: 277-90.

12. Khalili J., H.F. Biloklytska. Salivary malondialdehyde levels in clinically healthy and periodontal disease individuals. Oral Diseases. 2008; 14, 754-760.

13. Buduneli N., Kardesler L., Isik H. Effects of smoking and gin al inflammation on salivary antioxidant capacity. J Clin Periodontol 2006; 33 (3) 159-64.

14. Raju P., George R., Ramesh V.S., Arvind H., Baskaran M., Vijaya L. Influence of tobaccouse on cataract development. British Journal of Ophthalmology 2006; 9 (11): 1374-7.

15. Agnihotri R., Pandurang P., Kamath S.U., Goyal R, Banal S. Association of cigarette smoking with superoxide dispiutas enzyme levels in subjects with chronic periodontitis. J Periodontol 2009; 80 (4): 657-62.

16. Guentsch A., Preshaw P.M., Bremer-Streck S., Klinger G., Glockmann E., Sigusch B.W. Lipid peroxidation and antioxidant activity in saliva of periodontitis patients: effect of smoking and peri1odontal treatment Clinical Oral Investigations 2008; 12 (4) 345-52.

17. Ah M. K., Johnson G. K., Kaldahl W. B., Patil K. D., Kalkwarf K. L. The effect of smoking on the response to periodontal therapy. J Clini periodontology 1994; 21 (2): 91-7.

18. Javed F., Altamash M., Kling B., Engstrom P.E. Periodontal conditions and oral symptoms in Gutka chewers with and without type 2 diabetes. Acta Odontol scand. 2008; 66: 268-273.

19. Priscillla W., Joel E. The Oral Effects of Smokeless Tobacco. J Can Dental Assoc. 2000; 66: 22-5.

20. Main J.H., Lecavalier D.R. Smokeless tobacco and oral disease. J Can Dent Assoc. 1988; 54: 586-91.

21. Johnson O.K., Hill M. Cigarette smoking and the periodontal patient. J Periodontol 2004; 75: 196-209.

22. Chapple I.L., Matthews J.B. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000. 2007; 43: 160-232.

23. Halliwell B., Whiteman M. Measuring reactive species and antioxidative damage in vivo and cell culture: how should you do it and what do the results mean. Br J Phannacol 2004;142: 31-255.

24. Panjamurthy K., Manoharan S., Ramachandran C. Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett 2005;10: 255-264.

25. Celec P. Hodosy J., Celecova V. et al. Salivary thiobarbituricacid reacting substances and malondialdehyde-their relationship to reported smoking and to periodontal status described by the papillary bleeding index. Disease Markers 2005; 21: 133-137.

26. Akalin F.A., Baltacioglu E., Alver A. et al. Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol 2007; 34: 558-565.